These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 307270)

  • 21. Urinary excretion of D-glucaric acid, total glucuronic acid and total porphyrins in porphyria cutanea tarda.
    Budillon G; Ayala F; Carrella M; Mazzacca G
    Acta Hepatogastroenterol (Stuttg); 1978 Aug; 25(4):267-70. PubMed ID: 696201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual porphyria of coexisting variegata and cutanea tarda.
    Sieg I; Bhutani LK; Doss MO
    Eur J Clin Chem Clin Biochem; 1995 Jul; 33(7):405-10. PubMed ID: 7548446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ACQUIRED PORPHYRIA CUTANEA TARDA: REPORT OF A CASE SUCCESSFULLY TREATED BY PHLEBOTOMY.
    KOVAL A; DANBY CW; PETERMANN H
    Can Med Assoc J; 1965 Sep; 93(10):537-40. PubMed ID: 14341652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of porphyria cutanea tarda with intermittent chloroquine].
    Raff M; Formanek I
    Hautarzt; 1980 Aug; 31(8):437-40. PubMed ID: 7451150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Porphyria cutanea tarda and pregnancy.
    Goerz G; Hammer G
    Dermatologica; 1983 Jun; 166(6):316-8. PubMed ID: 6884554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma porphyrins in the porphyrias.
    Hindmarsh JT; Oliveras L; Greenway DC
    Clin Chem; 1999 Jul; 45(7):1070-6. PubMed ID: 10388484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary excretion of D-glucaric acid in porphyria cutanea tarda.
    Tutor JC; Lopez-Urrutia A; Fernandez MP
    J Clin Chem Clin Biochem; 1987 Dec; 25(12):855-8. PubMed ID: 2895161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Five cases of porphyria cutanea tarda with mild cutaneous changes: evaluation of the efficacy of phlebotomy by the pattern analysis of urinary porphyrins.
    Nonaka S; Ohgami T; Murayama F; Yamashita K; Yoshida H
    J Dermatol; 1986 Jun; 13(3):196-202. PubMed ID: 3537046
    [No Abstract]   [Full Text] [Related]  

  • 29. On accuracy and precision of a HPLC method for measurement of urine porphyrin concentrations.
    Zuijderhoudt FM; Koehorst SG; Kluitenberg WE; Dorresteijn-de Bok J
    Clin Chem Lab Med; 2000 Mar; 38(3):227-30. PubMed ID: 10905759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A study of an automated porphyria diagnosis system using urinary porphyrin profile analysis].
    Fujioka Y; Yanagisawa H; Kondo M
    Nihon Rinsho; 1995 Jun; 53(6):1395-401. PubMed ID: 7616653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Does paraneoplastic porphyria cutanea tarda exist?].
    Köstler E
    Dtsch Z Verdau Stoffwechselkr; 1988; 48(1):35-40. PubMed ID: 3371236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cimetidine in the treatment of porphyria cutanea tarda.
    Horie Y; Tanaka K; Okano J; Ohgi N; Kawasaki H; Yamamoto S; Kondo M; Sassa S
    Intern Med; 1996 Sep; 35(9):717-9. PubMed ID: 8915698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolation and characterization of new porphyrin metabolites in human porphyria cutanea tarda and in rats treated with hexachlorobenzene by HPTLC, HPLC and liquid secondary ion mass spectrometry.
    Luo J; Lim CK
    Biomed Chromatogr; 1995; 9(3):113-22. PubMed ID: 7655298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic fluorescence in porphyria cutanea tarda studied in fine needle aspiration biopsy smears.
    Lundvall O; Enerbäck L
    J Clin Pathol; 1969 Nov; 22(6):704-9. PubMed ID: 5365345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydroxychloroquine versus phlebotomy in the treatment of porphyria cutanea tarda.
    Cainelli T; Di Padova C; Marchesi L; Gori G; Rovagnati P; Podenzani SA; Bessone E; Cantoni L
    Br J Dermatol; 1983 May; 108(5):593-600. PubMed ID: 6849826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary excretion of position isomers of penta-and hexa-carboxylated porphyrins belonging to the isomer III series in a case of congenital erythropoietic porphyria.
    Eriksen L; Eriksen N
    Scand J Clin Lab Invest; 1977 Jun; 37(4):357-61. PubMed ID: 616062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Data on the elimination of porphyrin in urine in porphyria cutanea tarda].
    NAZZARO P; TOPI GC; VENERANDO A
    Boll Soc Ital Biol Sper; 1955; 31(11-12):1670-2. PubMed ID: 13329261
    [No Abstract]   [Full Text] [Related]  

  • 38. Urinary porphyrin analyses in patients with porphyria cutanea tarda.
    Nonaka S; Ogami T; Yoshida K; Honda T; Murayama F; Yoshida H
    J Dermatol; 1982 Oct; 9(5):397-404. PubMed ID: 6761381
    [No Abstract]   [Full Text] [Related]  

  • 39. Thin layer chromatography and fluorescent scanning analysis of porphyrins.
    Miura T; Torinuki W
    Tohoku J Exp Med; 1977 Jan; 121(1):57-61. PubMed ID: 835139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ascorbate status of patients with porphyria cutanea tarda symptomatica and its effect on porphyrin metabolism.
    Percy VA; Naidoo D; Joubert SM; Pegoraro RJ
    S Afr J Med Sci; 1975; 40(4):185-96. PubMed ID: 1209393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.